Shore Capital reissued their not rated rating on shares of Genus (LON:GNS – Free Report) in a research note released on Friday, MarketBeat Ratings reports.
Genus Trading Up 4.5 %
LON:GNS opened at GBX 1,718 ($21.63) on Friday. Genus has a 1-year low of GBX 1,478 ($18.61) and a 1-year high of GBX 2,378 ($29.95). The business’s 50-day moving average price is GBX 1,955.79 and its two-hundred day moving average price is GBX 1,837.12. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The firm has a market capitalization of £1.13 billion, a price-to-earnings ratio of 14,316.67, a PEG ratio of 2.87 and a beta of 0.37.
Genus Increases Dividend
The firm also recently declared a dividend, which will be paid on Friday, December 6th. Stockholders of record on Thursday, November 7th will be given a dividend of GBX 21.70 ($0.27) per share. The ex-dividend date of this dividend is Thursday, November 7th. This represents a dividend yield of 1.21%. This is a positive change from Genus’s previous dividend of $10.30. Genus’s dividend payout ratio (DPR) is currently 26,666.67%.
Insider Transactions at Genus
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Articles
- Five stocks we like better than Genus
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Disney’s Magic Strategy: Reinventing the House of Mouse
- 3 Warren Buffett Stocks to Buy Now
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- The How and Why of Investing in Gold Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.